![Henrik Harling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henrik Harling served as the Chairman of the Danish Colorectal Cancer Group from 1994 to 2010.
He also worked as the Chief Medical Officer at 2cureX AB from 2019 to 2022.
| Unternehmen | Position | Ende |
|---|---|---|
| 2CUREX AB | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2022 |
Danish Colorectal Cancer Group | Vorsitzender | 01.01.2010 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
2cureX AB
 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices | Health Technology |
Danish Colorectal Cancer Group |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
